Out-of-pocket cost of screening with breast MRI for women at high risk for breast cancer.

Authors

null

I-Wen Pan

University of Texas MD Anderson Cancer Center, Houston, TX

I-Wen Pan , Kevin C. Oeffinger , Ya-Chen T. Shih

Organizations

University of Texas MD Anderson Cancer Center, Houston, TX, Duke University, Durham, NC, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Funding

U.S. National Institutes of Health
U.S. National Institutes of Health

Background: The prevention provision of Affordable Care Act (ACA) mandates private insurance to waive cost sharing for preventive services with grade A or B recommendations from the US Preventive Services Task Force. Although several professional societies have recommended augmenting screening mammography with MRI for women at high risk for breast cancer, the ACA prevention provision does not apply to screening MRI. This study examined the proportion of high-risk women having zero cost sharing associated with breast MRI for screening purposes and estimated out of pocket (OOP) costs as well as sources of variations. Methods: We identified women who underwent MRI and mammography for breast cancer screening from Marketscan database, 2009-2017. We quantified OOP costs as the sum of copayment, coinsurance, and deductible and defined zero cost sharing as having no OOP cost. We calculated the proportion of zero cost sharing for mammography and that for MRI and compared the time trend of each before and after ACA (enacted in 2010). We used multivariable logistic regression to examine factors associated with zero cost sharing for MRI use. We estimated OOP costs of MRI and examined cost variations by geographic regions or whether a woman had high deductible plans. Results: 25,232 women were included in the analysis. For screening mammography, the rate of zero cost sharing increased from 81% in 2009 to 91% in 2011 (post ACA) then 97% in 2017. For MRI, the rate was 41%, 37%, and 25%, respectively. The odds ratio (OR) of zero cost sharing for MRI screening was significantly lower for women with high deductible plans (OR = 0.65, 95% CI: 0.59-0.72) and for those resided in South (vs. Northeast) region (OR = 0.50, 95% CI: 0.46-0.53), after controlling for age, MSA, family breast cancer history, and year. OOP costs of MRI varied by region and insurance plan (Table); the mean OOP cost for women with high deductible plan were more than twice the mean cost for those in other plan types. Conclusions: With the financial protection under the ACA prevention provision applying to only screening mammography, many women at high risk for breast cancer are subject to high OOP costs for MRI screening. Those enrolled in high deductible plans and resided in the South are especially vulnerable financially.

OOP costs (USD) for screening MRI, by insurance plan and region.

SubgroupCategoryNo. of CasesMeanSTDP25MedianP75
Total25232271449088359
High DeductibleNo22602240403076323
Yes26305376823246843
RegionNortheast7159189411020172
Midwest51832954590123393
South79943314860162462
West48962654120113362

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Health and Regulatory Policy

Citation

J Clin Oncol 38: 2020 (suppl; abstr 2017)

DOI

10.1200/JCO.2020.38.15_suppl.2017

Abstract #

2017

Poster Bd #

9

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Uptake of screening MRI in high risk patients without a personal history of breast cancer.

First Author: Luciarita Boccuzzi

First Author: Sasmith Menakuru

First Author: Matthew Culbert